LPCN Latest Press Releases

-- November 5, 2026 --

Lipocine Announces Financial Results for the Third Quarter of 2026 PRNewswire 8:00 AM

-- October 7, 2026 --

Lipocine Announces Health Canada Approval of TLANDO for Testosterone Replacement Therapy PRNewswire 8:01 AM

-- September 14, 2026 --

Lipocine Announces Initiation of BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression PRNewswire 8:00 AM

-- September 10, 2026 --

Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference PRNewswire 8:01 AM

-- August 4, 2026 --

Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026 PRNewswire 8:00 AM

-- August 3, 2026 --

Lipocine Appoints Michael J. Grissinger to Board of Directors PRNewswire 8:00 AM

Market Data Delayed 15 Minutes